文献

J-GLOBAL ID：201902242547700982   整理番号：19A2239240

27か国の冠動脈患者における心血管系リスク因子制御に対するライフスタイルと影響:ヨーロッパ心臓学会ESC-EORP Euroaspire V登録からの結果【JST・京大機械翻訳】

Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry

著者 (84件)： Kotseva Kornelia (European Society of Cardiology, Sophia Antipolis, France) ,  Kotseva Kornelia (National Heart and Lung Institute, Imperial College London, UK) ,  De Backer Guy (European Society of Cardiology, Sophia Antipolis, France) ,  De Backer Guy (Department of Public Health and Primary Care, Ghent University, Belgium) ,  De Bacquer Dirk (European Society of Cardiology, Sophia Antipolis, France) ,  De Bacquer Dirk (Department of Public Health and Primary Care, Ghent University, Belgium) ,  Ryden Lars (European Society of Cardiology, Sophia Antipolis, France) ,  Ryden Lars (Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden) ,  Hoes Arno (European Society of Cardiology, Sophia Antipolis, France) ,  Hoes Arno (Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, The Netherlands) ,  Grobbee Diederick (European Society of Cardiology, Sophia Antipolis, France) ,  Grobbee Diederick (Julius Global Health, Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, The Netherlands) ,  Maggioni Aldo (European Society of Cardiology, Sophia Antipolis, France) ,  Maggioni Aldo (ANMCO Research Centre, Florence, Italy) ,  Marques-Vidal Pedro (European Society of Cardiology, Sophia Antipolis, France) ,  Marques-Vidal Pedro (Department of Medicine, Internal Medicine, Lausanne University Hospital, Switzerland) ,  Jennings Catriona (European Society of Cardiology, Sophia Antipolis, France) ,  Jennings Catriona (National Heart and Lung Institute, Imperial College London, UK) ,  Abreu Ana (Hospital Santa Marta, Centro Hospitalar de Lisboa Central, Lisbon, Portugal) ,  Aguiar Carlos (European Society of Cardiology, Sophia Antipolis, France) ,  Aguiar Carlos (Hospital Santa Cruz, Centro Hospitalar de Lisboa Ocidental, Lisbon, Portugal) ,  Badariene Jolita (Clinic of Cardiac and Vascular diseases, Medical Faculty, Vilnius University, Lithuania) ,  Badariene Jolita (Centre of Cardiology and Angiology, Vilnius University Hospital Santaros Klinikos, Lithuania) ,  Bruthans Jan (European Society of Cardiology, Sophia Antipolis, France) ,  Bruthans Jan (Centre for Cardiovascular Prevention, Charles University in Prague, First Faculty of Medicine and Thomayer Hospital, Czech Republic) ,  Castro Conde Almudena (Cardiac Rehabilitation Unit, Cardiology Department, Hospital Universitario La Paz, Madrid, Spain) ,  Cifkova Renata (European Society of Cardiology, Sophia Antipolis, France) ,  Cifkova Renata (Centre for Cardiovascular Prevention, Charles University in Prague, First Faculty of Medicine and Thomayer Hospital, Czech Republic) ,  Crowley Jim (European Society of Cardiology, Sophia Antipolis, France) ,  Crowley Jim (Department of Cardiology, Galway University Hospital and Croi, the West of Ireland Cardiac and Stroke Foundation, Croi Heart and Stroke Centre, Galway, Ireland) ,  Davletov Kairat (School of Public Health, Public Health Research Centre, Kazakh National Medical University, Almaty, Kazakhstan) ,  Deckers Jaap (European Society of Cardiology, Sophia Antipolis, France) ,  Deckers Jaap (Erasmus MC, Rotterdam, The Netherlands) ,  De Smedt Delphine (European Society of Cardiology, Sophia Antipolis, France) ,  De Smedt Delphine (Department of Public Health and Primary Care, Ghent University, Belgium) ,  De Sutter Johan (European Society of Cardiology, Sophia Antipolis, France) ,  De Sutter Johan (Department of Internal Medicine and Paediatrics, Ghent University, Belgium) ,  De Sutter Johan (AZ Maria Middelares Ghent, Belgium) ,  Dilic Mirza (European Society of Cardiology, Sophia Antipolis, France) ,  Dilic Mirza (Medical Faculty, University of Sarajevo, Bosnia and Herzegovina) ,  Dolzhenko Marina (Supyk National Medical Academy of Postgraduate Education, Kiev, Ukraine) ,  Dzerve Vilnis (European Society of Cardiology, Sophia Antipolis, France) ,  Dzerve Vilnis (Institute of Cardiology and Regenerative Medicine, University of Latvia, Riga, Latvia) ,  Erglis Andrejs (European Society of Cardiology, Sophia Antipolis, France) ,  Erglis Andrejs (Pauls Stradins Clinical University Hospita, University of Latvia, Riga, Latvia) ,  Fras Zlatko (European Society of Cardiology, Sophia Antipolis, France) ,  Fras Zlatko (Preventive Cardiology Unit, Department of Vascular Medicine, Division of Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia) ,  Fras Zlatko (Medical Faculty, University of Ljubljana, Slovenia) ,  Gaita Dan (European Society of Cardiology, Sophia Antipolis, France) ,  Gaita Dan (Universitatea de Medicina si Farmacie Victor Babes, Institutul de Boli Cardiovasculare, Clinica de Recuperare Cardiovasculara, Timisoara, Romania) ,  Gotcheva Nina (National Heart Hospital, Dept Cardiology, Sofia, Bulgaria) ,  Heuschmann Peter (Institute of Clinical Epidemiology and Biometry, University of Wuerzburg, Germany) ,  Heuschmann Peter (Clinical Trial Centre, University Hospital Wuerzburg, Germany) ,  Heuschmann Peter (Comprehensive Heart Failure Centre, University and University Hospital Wuerzburg, Germany) ,  Hasan-Ali Hosam (Assiut University Heart Hospital, Cardiovascular Medicine Department, Egypt) ,  Jankowski Piotr (Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland) ,  Lalic Nebojsa (Department for Metabolic Disorder, Intensive Treatment and Cell Therapy in Diabetes, Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Centre of Serbia, Belgrade, Serbia) ,  Lehto Seppo (European Society of Cardiology, Sophia Antipolis, France) ,  Lehto Seppo (Varkaus Hospital, Finland) ,  Lovic Dragan (European Society of Cardiology, Sophia Antipolis, France) ,  Lovic Dragan (Clinic for Internal Disease Intermedic, Cardiology Department, Hypertension Centre, Nis, Serbia) ,  Mancas Silvia (Universitatea de Medicina si Farmacie Victor Babes, Institutul de Boli Cardiovasculare, Clinica de Recuperare Cardiovasculara, Timisoara, Romania) ,  Mellbin Linda (European Society of Cardiology, Sophia Antipolis, France) ,  Mellbin Linda (Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden) ,  Milicic Davor (European Society of Cardiology, Sophia Antipolis, France) ,  Milicic Davor (University of Zagreb School of Medicine & University Hospital Centre Zagreb, Croatia) ,  Mirrakhimov Erkin (European Society of Cardiology, Sophia Antipolis, France) ,  Mirrakhimov Erkin (Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan) ,  Mirrakhimov Erkin (National Centre of Cardiology and Internal Medicine named after academician Mirrakhimov MM, Bishkek, Kyrgyzstan) ,  Oganov Rafael (National Research Centre for Preventive Medicine, Directorate, Moscow, Russia) ,  Pogosova Nana (Federal State Budget Organization, National Medical Research Centre of Cardiology of the Ministry of Healthcare of the Russian Federation, Moscow, Russia) ,  Reiner Zeljko (European Society of Cardiology, Sophia Antipolis, France) ,  Reiner Zeljko (University Hospital Centre Zagreb, School of Medicine, University of Zagreb, Croatia) ,  Stoerk Stefan (Comprehensive Heart Failure Centre, University and University Hospital Wuerzburg, Germany) ,  Stoerk Stefan (Department of Medicine I, University Hospital Wuerzburg, Germany) ,  Tokgozoglu Lale (European Society of Cardiology, Sophia Antipolis, France) ,  Tokgozoglu Lale (Department of Cardiology, Hacettepe University, Ankara, Turkey) ,  Tsioufis Costas (European Society of Cardiology, Sophia Antipolis, France) ,  Tsioufis Costas (First Department of Cardiology, Medical School, National and Kapodistrian University of Athens, Greece) ,  Vulic Dusko (Centre for Medical Research, School of Medicine, University of Banja Luka, Republic of Srpska, Bosnia and Herzegovina) ,  Wood David (European Society of Cardiology, Sophia Antipolis, France) ,  Wood David (National Heart and Lung Institute, Imperial College London, UK) ,  Wood David (National University of Ireland, Galway, Ireland *Listed in Supplemental Appendix) ,  on behalf of the EUROASPIRE Investigators*
資料名： European Journal of Preventive Cardiology  (European Journal of Preventive Cardiology)
巻： 26  号： 8  ページ： 824-835  発行年： 2019年 
JST資料番号： W5207A  ISSN： 2047-4873  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： アメリカ合衆国 (USA)  言語： 英語 (EN)

抄録/ポイント： 目的:本研究の目的は,二次心血管予防に関する共同ヨーロッパ社会ガイドラインが日常診療において追跡されるかどうかを決定することであった。設計:27か国の81地域における131センターにおける横断的ESC-EORP調査(EUROASPIRE V)。【方法】検証された冠状動脈イベントまたは介入を有する患者(<80歳)を面接し,6カ月後に検査した。結果:合計8261名の患者(女性26%)を面接した。喫煙者の19%とそれらの55%は持続的喫煙者であり,38%は肥満(ボディマスインデックス≧30kg/m2),59%は中心性肥満(胴囲:男性≧102cm;女性≧88cm)であり,66%は身体的に活性<30分5回/週であった。42%は,血圧≧140/90mmHg(糖尿病の場合≧140/85)を有し,71%は低密度リポ蛋白質コレステロール≧1.8mmol/L(≧70mg/dL),29%は糖尿病と報告されていた。心臓保護薬は,抗血小板93%,β遮断薬81%,アンギオテンシン変換酵素阻害剤/アンギオテンシン受容体遮断薬75%およびスタチン80%であった。結論:大多数の冠動脈患者は,喫煙,食事および座りやすい行動に関して健康でないライフスタイルを有し,それは主な心血管危険因子に悪影響を与える。大多数は血圧,低密度リポ蛋白質コレステロール及びグルコース標的を達成しなかった。心血管予防は,再発性心血管イベントのリスクを低減するために,ライフスタイルとリスク因子管理のすべての側面を扱う医療専門家の学際的チームによって提供された現代の予防的心臓学プログラムを必要とする。Copyright The European Society of Cardiology 2019 Translated from English into Japanese by JST.【JST・京大機械翻訳】

シソーラス用語： *冠動脈 ,  糖尿病 ,  男性 ,  再発 ,  *ライフスタイル ,  女性 ,  血圧 ,  *心臓 ,  *ヒト ,  *ヨーロッパ ,  予防 ,  肥満 ,  *危険因子 ,  ウエスト周囲径 ,  BMI ,  肥満度
準シソーラス用語： ボディマスインデックス ,  喫煙者 , 【Automatic Indexing@JST】

著者キーワード (5件)： Euroaspire ,  ライフスタイル ,  心血管危険因子 ,  二次予防 ,  ガイドライン

分類 (1件)： 代謝異常・栄養性疾患一般  (GD05010J)

タイトルに関連する用語 (9件)： 冠動脈 ,  患者 ,  心血管系 ,  リスク因子 ,  ライフスタイル ,  ヨーロッパ ,  心臓 ,  学会 ,  ESC